N/A
Completed N=396,983
Tianjin Diabetes and Health Cohort Study
Source: ClinicalTrials.gov NCT06913153 ↗Enrolled (actual)
396,983
Serious AEs
—
Results posted
May 2025
Primary outcomePrimary: Diabetes Complications — 10263; 97864; 59029; 69822 Participants
Summary
The goal of this observational study is to reveal the natural history of diabetes and the occurrence and development patterns of its complications, to evaluate the effectiveness of diabetes interventions, and to assess the health and medical burdens caused by diabetes in Tianjin, based on the medical records and health big data in Tianjin and correspondingly constructed diabetes-specific cohort.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diabetes Complications |
10263; 97864; 59029; 69822; 386720; 299119 | — |
| SECONDARY Glycemic Control |
8.7 | — |
| SECONDARY Death |
21669; 375314 | — |
Eligibility Criteria
Inclusion Criteria
- Patients diagnosed with diabetes
- Patients with three or more recorded visits
- The following information was complete at the first visit: age, sex, Blood Glucoseor ,glycated hemoglobin(HbA1c)
Exclusion Criteria
- none
Data sourced from ClinicalTrials.gov (NCT06913153). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.